<DOC>
	<DOCNO>NCT00140062</DOCNO>
	<brief_summary>The primary purpose compare intraocular pressure reduce effect Xalatan usual care 36 month . Safety health care utilization evaluate .</brief_summary>
	<brief_title>Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Unilateral bilateral openangle glaucoma , exfoliative glaucoma , pigmentary glaucoma ocular hypertension IOP &gt; 21 mm Hg current treatment Any previous current treatment latanoprost prostaglandin analogue</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>